National Storage Mechanism | Additional information
RNS Number : 9446F
T Stamp Inc
20 November 2020
 

Pre-Admission Announcement
Euronext Growth Schedule 1

Announcement to be made by the Applicant prior to admission in accordance with the Euronext Growth Markets Rule Book

 

All Applicants must complete the following

 

Company name 

T Stamp Inc ("Trust Stamp" or the "Company", and together with its subsidiaries the "Group")

 

Company registered address and if different, company trading address (including postcodes)

 

3017 Bolling Way North East Buckhead, 1st and 2nd Floor, Atlanta, GA 30305, United States

 

 

Country of incorporation  

 

United States of America

   

 

 

Company website address containing all information required by rule 26 (5.26) of the Euronext Growth Markets Rule Books

 

https://truststamp.ai/

 

Company business (including main country of operation) or, in the case of an investing company, details of its investing strategy. If the admission is sought as a result of a reverse takeover under rule 5.19 of the Euronext Growth Markets Rule Books, this should be stated

 

Trust Stamp is an artificial intelligence company that primarily develops proprietary identity solutions to help determine whether an individual is who they say they are and that they can be trusted, including Trust Stamp's AI-powered facial biometrics that establish proof of life and are resistant to presentation attacks. The Group's solutions revolve around a proprietary process by which a deep neural network irreversibly converts biometric and other identifying data, from any source, into an Irreversibly Transformed Identity Token (IT2) which serves as a secure tokenized identity. This hash is unique to the user but cannot be reverse engineered and rebuilt into the user's face or other biometric data.

 

Trust Stamp's main countries of operation are the United States, the UK, Poland and Malta.

 

 

 

 

Details of securities to be admitted including any restrictions as to transfer of securities (i.e. where known, number of shares, nominal value and issue price to which it seeks admission and the number and type to be held as treasury shares):

 

Number of shares of Class A common stock in the Company at $0.01 par value per share ("Common Shares") for which Admission will be sought: 3,588,651

 

There are no restrictions as to the transfer of the Common Shares.

 

263,230[1] shares will be held in treasury on Admission.

 

 

 

     

 

Capital to be raised on admission (if applicable) and anticipated market capitalisation on admission:

Capital to be raised: N/A

Anticipated market capitalisation on Admission: c.$28 million.

 

Percentage of Euronext Growth securities not in public hands on admission

 

 

 

55.6%

 

Details of any other exchange or trading platform to which the admitted securities (or other securities of the company) are or will be admitted or traded:

 

N/A

 

Full names and functions of directors and proposed directors (underlining the first name by which each is known or including any other name by which each is known):

 

Gareth Genner, Chief Executive Officer

 

Andrew Gowasack, President

 

David Story, Executive Chairman

 

Mark Birschbach, Non-executive Director

 

Stacia Hylton, Independent Non-executive Director (Proposed)

 

Jane Karowski McCracken, Independent Non-Executive Director (Proposed)

 

Sarah-Jill Lennard, Independent Non-Executive Director (Proposed)

 

William (Billy) D'Arcy, Independent Non-executive Director (Proposed)

 

 

 

Full names and holdings of significant shareholders, expressed as a percentage of the issued share capital, before or after admission (underlining the first name by which each is known or including any other name by which each is known):

 

Common Shares expected in issue on Admission: 3,588,651

 

Significant shareholders information

 

Shareholder Name

Common Shares held

Shareholding %

FSH Capital LLC

505,247

14.1%

Brent De Jong

274,493

7.7%

Andrew Gowasack

243,086

6.8%

Gareth Genner

203,319

5.7%

10Clouds

121,952

3.4%

 

 

Names of all persons to be disclosed in accordance with Chapter 5: Schedule Two, paragraph (h) of the Euronext Growth Markets Rule Book:

 

 

N/A

 

i       anticipated accounting reference date: 31 December

 

ii      date to which the main financial information in the admission document has been prepared: 30 June 2020

 

 

iii. dates by which it must publish its first three reports pursuant to Rules 5.14 and 5.15 in the Euronext Growth Markets Rule Book:

 

·    30 June 2021 (for its annual audited accounts for the year ended 31 December 2020)

·    30 September 2021 (for its unaudited interim accounts for the six months ended 30 June 2020)

·    30 June 2022 (for its annual audited accounts for the year ended 31 December 2021)

 

 

Expected admission date

Early-December 2020 

 

 

Name and address of Euronext Growth Advisor

 

Davy Corporate Finance,

Davy House,

49 Dawson Street,

Dublin 2,

Ireland

 

 

Name and address of broker

 

 

J&E Davy,

Davy House,

49 Dawson Street,

Dublin 2,

Ireland

 

Other than in the case of a Quoted Applicant, details of where (postal or internet address) the admission document will be available from, with a statement that this will contain full details about the Applicant and the admission of its securities

 

Copies of the admission document will be available for download at www.truststamp.ai from the date of admission. The admission document will contain full details about the applicant and the admission of its securities.

 

Date of notification 

20 November 2020

 

 

 

New/update: New

 

       

[1] All shares held in treasury on behalf of T Stamp Incentive Holdings ("TSIH"). The Board of the Company can use Common Shares held by TSIH for employee, consultant, advisor and other incentive stock awards in the future.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCGPGCCGUPUGBB